[Tanakan in the treatment of cognitive and autonomic impairments and headache in young patients].
To determine the efficacy and tolerability of tanakan in the treatment of memory and attention impairments in young patients. We studied 30 outpatients (24 women and 6 men, mean age 33,5±7,5 years) with headache, memory and attention impairments and decrease in mental working capacity. Treatment duration was 90 days. Patients received tanakan in dose 40 mg 3 times per day to restore cognitive function. The study design included 4 visits during which patients completed questionnaires and scales. All patients reported positive changes in mood, memory, information learning and working capacity. Headaches of tension decreased by 50%, vertigo and noise in ears became less intense, autonomic disturbances practically disappeared. No effect on the frequency of migrainous attacks was found. Tanakan is effective and safe for symptomatic therapy of cognitive impairment in any age, including young patients.